BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review. Clin Microbiol Infect 2021:S1198-743X(21)00604-2. [PMID: 34715347 DOI: 10.1016/j.cmi.2021.10.005] [Cited by in Crossref: 117] [Cited by in F6Publishing: 22] [Article Influence: 117.0] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Xu Y, Li X, Liu W, Yao D, Chen W, Yu H, He L, Lu S, Jiang C, Zhu W, Meng L. Real-world effectiveness and protection of SARS-CoV-2 vaccine among patients hospitalized for COVID-19 in Xi’an, China, December 8, 2021, to January 20, 2022: A retrospective study. Front Immunol 2022;13:978977. [DOI: 10.3389/fimmu.2022.978977] [Reference Citation Analysis]
2 Yu S, He Y, Ji W, Yang R, Zhao Y, Li Y, Liu Y, Ding L, Ma M, Wang H, Yang X. Metabolic and Proteomic Profiles Associated with Immune Responses Induced by Different Inactivated SARS-CoV-2 Vaccine Candidates. IJMS 2022;23:10644. [DOI: 10.3390/ijms231810644] [Reference Citation Analysis]
3 Feng Y, Quan Y, Cassady K, Zou Z, Gao Y, Zhang X. Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination. Hum Vaccin Immunother 2022;:2119043. [PMID: 36069667 DOI: 10.1080/21645515.2022.2119043] [Reference Citation Analysis]
4 Jonny J, Putranto TA, Irfon R, Sitepu EC. Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic. Front Immunol 2022;13:989685. [DOI: 10.3389/fimmu.2022.989685] [Reference Citation Analysis]
5 Najafi-fard S, Petruccioli E, Farroni C, Petrone L, Vanini V, Cuzzi G, Salmi A, Altera AMG, Navarra A, Alonzi T, Nicastri E, Palmieri F, Gualano G, Carlini V, Noonan DM, Albini A, Goletti D. Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy. Front Immunol 2022;13:984098. [DOI: 10.3389/fimmu.2022.984098] [Reference Citation Analysis]
6 Alimohammadi R, Porgoo M, Eftekhary M, Kiaie SH, Ansari Dezfouli E, Dehghani M, Nasrollahi K, Malekshahabi T, Heidari M, Pouya S, Alimohammadi M, Sattari Khavas D, Modaresi MS, Ghasemi MH, Ramyar H, Mohammadipour F, Hamzelouei F, Mofayezi A, Mottaghi SS, Rahmati A, Razzaznian M, Tirandazi V, Tat M, Borzouee F, Sadeghi H, Haji Mohammadi M, Rastegar L, Safar Sajadi SM, Ehsanbakhsh H, Bazmbar H, Baghernejadan Z, Shams Nouraei M, Pazooki P, Pahlavanneshan M, Alishah K, Nasiri F, Mokhberian N, Mohammadi SS, Akar S, Niknam H, Azizi M, Ajoudanian M, Moteallehi-Ardakani MH, Mousavi Shaegh SA, Ramezani R, Salimi V, Moazzami R, Hashemi SM, Dehghanizadeh S, Khoddami V. SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates. NPJ Vaccines 2022;7:105. [PMID: 36056015 DOI: 10.1038/s41541-022-00528-3] [Reference Citation Analysis]
7 Roy D, Rahman MM, Chaity AS, Reza MA, Haque A. Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population. Sci Rep 2022;12:14681. [PMID: 36038600 DOI: 10.1038/s41598-022-18302-9] [Reference Citation Analysis]
8 Hou Y, Wu C, Lu K, Kuo K. Indoxyl Sulfate Alters the Humoral Response of the ChAdOx1 COVID-19 Vaccine in Hemodialysis Patients. Vaccines 2022;10:1378. [DOI: 10.3390/vaccines10091378] [Reference Citation Analysis]
9 Ferrara P, Ponticelli D, Magliuolo R, Borrelli M, Schiavone B, Mantovani LG. Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study. Vaccines (Basel) 2022;10:1353. [PMID: 36016240 DOI: 10.3390/vaccines10081353] [Reference Citation Analysis]
10 Campos DMO, Silva MKD, Barbosa ED, Leow CY, Fulco UL, Oliveira JIN. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants. Comput Biol Chem 2022;101:107754. [PMID: 36037724 DOI: 10.1016/j.compbiolchem.2022.107754] [Reference Citation Analysis]
11 Brehm J, Spaeth A, Dreßler L, Masetto T, Dannenberg R, Peter C, Grimmler M. SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study. Front Immunol 2022;13:915338. [DOI: 10.3389/fimmu.2022.915338] [Reference Citation Analysis]
12 Caputo E, Mandrich L. Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants. Life (Basel) 2022;12:1245. [PMID: 36013424 DOI: 10.3390/life12081245] [Reference Citation Analysis]
13 Zee S, Kwok L, Kee K, Fung L, Luk W, Chan T, Leung C, Yu P, Hung J, Szeto K, Chan W, Tang S, Lin W, Ma S, Lee K, Lau C, Yung W. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong. Vaccines 2022;10:1322. [DOI: 10.3390/vaccines10081322] [Reference Citation Analysis]
14 Md Khairi LNH, Fahrni ML, Lazzarino AI. The Race for Global Equitable Access to COVID-19 Vaccines. Vaccines (Basel) 2022;10:1306. [PMID: 36016194 DOI: 10.3390/vaccines10081306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Delshad M, Sanaei MJ, Pourbagheri-Sigaroodi A, Bashash D. Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination. Int Immunopharmacol 2022;111:109128. [PMID: 35963158 DOI: 10.1016/j.intimp.2022.109128] [Reference Citation Analysis]
16 da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Reference Citation Analysis]
17 Voulgaridi I, Sarrou S, Dadouli A, Peristeri AM, Nasika A, Onoufriadis I, Kyritsi MA, Anagnostopoulos L, Theodoridou A, Avakian I, Pappa D, Konstantinou AK, Papadamou G, Mouchtouri VA, Petinaki E, Speletas M, Hadjichristodoulou C. Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines. Vaccines (Basel) 2022;10:1268. [PMID: 36016156 DOI: 10.3390/vaccines10081268] [Reference Citation Analysis]
18 Shi X, Zhang Y, Zhou L, Zhou L, Qiao H. Influenza vaccination coverage among health-care workers during the COVID-19 epidemic in 2020/2021 influenza season: Evidence from a web-based survey in northwestern China. Hum Vaccin Immunother 2022;:2102354. [PMID: 35920744 DOI: 10.1080/21645515.2022.2102354] [Reference Citation Analysis]
19 Matsumura Y, Nagao M, Yamamoto M, Tsuchido Y, Noguchi T, Shinohara K, Yukawa S, Inoue H, Ikeda T. Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021. Emerg Infect Dis 2022;28. [PMID: 35710464 DOI: 10.3201/eid2808.220420] [Reference Citation Analysis]
20 Chen Y, Guo Y, Song Z, Chang H, Kuang Q, Zheng Z, Wang H, Zhang G. Luteolin restricts ASFV replication by regulating the NF-κB/STAT3/ATF6 signaling pathway. Veterinary Microbiology 2022. [DOI: 10.1016/j.vetmic.2022.109527] [Reference Citation Analysis]
21 Zhang Y, Zheng X, Sheng W, Liang H, Zhao Y, Zhu X, Yang R, Zhang Y, Dong X, Li W, Pei F, Ding L, Chang Z, Deng L, Yuan G, Yang Z, Zhu D, Yang X, Wang H. Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants. Vaccines (Basel) 2022;10:1208. [PMID: 36016098 DOI: 10.3390/vaccines10081208] [Reference Citation Analysis]
22 Román LE, Villalva C, Uribe C, Paraguay-delgado F, Sousa J, Vigo J, Vera CM, Gómez MM, Solís JL. Textiles Functionalized with Copper Oxides: A Sustainable Option for Prevention of COVID-19. Polymers 2022;14:3066. [DOI: 10.3390/polym14153066] [Reference Citation Analysis]
23 Eldokla AM, Numan MT. Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine. Clin Auton Res. [DOI: 10.1007/s10286-022-00880-3] [Reference Citation Analysis]
24 Abuhammad S, Khabour OF, Alzoubi KH, Hamaideh S, Alzoubi BA, Telfah WS, El-Zubi FK. The public's attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan. PLoS One 2022;17:e0271625. [PMID: 35857813 DOI: 10.1371/journal.pone.0271625] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kim YE, Huh K, Park YJ, Peck KR, Jung J. Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection. JAMA 2022. [PMID: 35867050 DOI: 10.1001/jama.2022.12992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Vokó Z, Kiss Z, Surján G, Surján O, Barcza Z, Wittmann I, Molnár GA, Nagy D, Müller V, Bogos K, Nagy P, Kenessey I, Wéber A, Polivka L, Pálosi M, Szlávik J, Rokszin G, Müller C, Szekanecz Z, Kásler M. Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Front Immunol 2022;13:919408. [DOI: 10.3389/fimmu.2022.919408] [Reference Citation Analysis]
27 Feng T, Zhang M, Xu Q, Song F, Wang L, Gai S, Tang H, Wang S, Zhou L, Li H. Exploration of molecular targets and mechanisms of Chinese medicinal formula Acacia Catechu -Scutellariae Radix in the treatment of COVID-19 by a systems pharmacology strategy. Phytother Res 2022. [PMID: 35859316 DOI: 10.1002/ptr.7554] [Reference Citation Analysis]
28 Krakowczyk JB, Bäuerle A, Pape L, Kaup T, Nulle L, Teufel M, Skoda E. COVID-19 Vaccine for Children: Vaccination Willingness of Parents and Its Associated Factors—A Network Analysis. Vaccines 2022;10:1155. [DOI: 10.3390/vaccines10071155] [Reference Citation Analysis]
29 Keske Ş, Esken GG, Vatansever C, Beşli Y, Kuloğlu ZE, Nergiz Z, Barlas T, Şencanlı Ö, Kuşkucu MA, Palaoğlu E, Can F, Ergönül Ö. Duration of infectious shedding of SARS-CoV-2 omicron variant and its relation with symptoms. Clin Microbiol Infect 2022:S1198-743X(22)00373-1. [PMID: 35853589 DOI: 10.1016/j.cmi.2022.07.009] [Reference Citation Analysis]
30 Chavda VP, Sonak SS, Munshi NK, Dhamade PN. Pseudoscience and fraudulent products for COVID-19 management. Environ Sci Pollut Res Int 2022. [PMID: 35836045 DOI: 10.1007/s11356-022-21967-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zou Y, Huang D, Jiang Q, Guo Y, Chen C. The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis. Front Public Health 2022;10:940956. [DOI: 10.3389/fpubh.2022.940956] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Yong S, Halim A, Halim M, Al Mutair A, Alhumaid S, Al-sihati J, Albayat H, Alsaeed M, Garout M, Al Azmi R, Aldakheel N, Alshukairi AN, Al Ali HA, Almoumen AA, Rabaan AA. Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies. Vaccines 2022;10:1067. [DOI: 10.3390/vaccines10071067] [Reference Citation Analysis]
33 Upreti S, Samant M. A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens. Pharm Res 2022. [PMID: 35773445 DOI: 10.1007/s11095-022-03323-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Tonnara G, Piselli P, Cimaglia C, Arlotti M, Sacchini E, Manoni S, Zani A, Muccioli F, Laderchi A, Rabini S, Antinori A, Vaia F, Nicastri E, Girardi E. The impact of COVID-19 vaccination program in the Republic of San Marino: focus on effectiveness of Gam-COVID-Vac. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.06.026] [Reference Citation Analysis]
35 Duan C, Ma R, Zeng X, Chen B, Hou D, Liu R, Li X, Liu L, Li T, Huang H. SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19. Front Immunol 2022;13:946731. [DOI: 10.3389/fimmu.2022.946731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ortiz-prado E, Izquierdo-condoy JS, Fernandez-naranjo R, Simbaña-rivera K, Vásconez-gonzález J, Naranjo EPL, Cordovez S, Coronel B, Delgado-moreira K, Jimbo-sotomayor R. A Comparative Analysis of a Self-Reported Adverse Events Analysis after Receiving One of the Available SARS-CoV-2 Vaccine Schemes in Ecuador. Vaccines 2022;10:1047. [DOI: 10.3390/vaccines10071047] [Reference Citation Analysis]
37 Zhao M, Li C, Zhang J, Yin Z, Zheng Z, Wan J, Wang M. Maresin-1 and Its Receptors RORα/LGR6 as Potential Therapeutic Target for Respiratory Diseases. Pharmacol Res 2022;:106337. [PMID: 35781060 DOI: 10.1016/j.phrs.2022.106337] [Reference Citation Analysis]
38 Chaki SP, Kahl-McDonagh MM, Neuman BW, Zuelke KA. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Microbiol Spectr 2022;10:e0066522. [PMID: 35638906 DOI: 10.1128/spectrum.00665-22] [Reference Citation Analysis]
39 AlMutairi LT, Alalayet WY, Ata SI, Alenzi KA, AlRuthia Y. Self-Reported COVID-19 Vaccines' Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study. Vaccines (Basel) 2022;10:977. [PMID: 35746586 DOI: 10.3390/vaccines10060977] [Reference Citation Analysis]
40 Proia E, Ragno A, Antonini L, Sabatino M, Mladenovič M, Capobianco R, Ragno R. Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal. J Comput Aided Mol Des 2022. [PMID: 35716228 DOI: 10.1007/s10822-022-00460-7] [Reference Citation Analysis]
41 Saberiyan M, Karimi E, Khademi Z, Movahhed P, Safi A, Mehri-Ghahfarrokhi A. SARS-CoV-2: phenotype, genotype, and characterization of different variants. Cell Mol Biol Lett 2022;27:50. [PMID: 35715738 DOI: 10.1186/s11658-022-00352-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Mingot-Castellano ME, Butta N, Canaro M, Gómez Del Castillo Solano MDC, Sánchez-González B, Jiménez-Bárcenas R, Pascual-Izquierdo C, Caballero-Navarro G, Entrena Ureña L, José González-López T, On Behalf Of The Gepti. COVID-19 Vaccines and Autoimmune Hematologic Disorders. Vaccines (Basel) 2022;10:961. [PMID: 35746569 DOI: 10.3390/vaccines10060961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
43 Israel A, Schäffer AA, Merzon E, Green I, Magen E, Golan-Cohen A, Vinker S, Ruppin E. A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received. Microorganisms 2022;10:1238. [PMID: 35744754 DOI: 10.3390/microorganisms10061238] [Reference Citation Analysis]
44 Volckmar J, Melcher L, Bruder D. Route, origin & valence matter: towards sophisticated next-generation vaccines to cope with the COVID-19 pandemic. Signal Transduct Target Ther 2022;7:188. [PMID: 35705533 DOI: 10.1038/s41392-022-01053-4] [Reference Citation Analysis]
45 K A, Sharma A, Kumar D, Singh SK, Gupta G, Chellappan DK, Dua K, Nagraik R. Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review. J Med Virol 2022. [PMID: 35705439 DOI: 10.1002/jmv.27936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Bert F, Scaioli G, Vola L, Accortanzo D, Lo Moro G, Siliquini R. Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries. Int J Environ Res Public Health 2022;19:7233. [PMID: 35742479 DOI: 10.3390/ijerph19127233] [Reference Citation Analysis]
47 Le Gars M, Hendriks J, Sadoff J, Ryser M, Struyf F, Douoguih M, Schuitemaker H. Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine. Immunol Rev 2022. [PMID: 35689434 DOI: 10.1111/imr.13088] [Reference Citation Analysis]
48 Meng Z, Ma D, Duan S, Zhang J, Yue R, Li X, Gao Y, Li X, Zeng F, Xu X, Jiang G, Liao Y, Fan S, Niu Z, Li D, Yu L, Zhao H, Xu X, Wang L, Zhang Y, Liu L, Li Q. Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine. Vaccines (Basel) 2022;10:929. [PMID: 35746536 DOI: 10.3390/vaccines10060929] [Reference Citation Analysis]
49 Kawasuji H, Morinaga Y, Tani H, Saga Y, Kaneda M, Murai Y, Ueno A, Miyajima Y, Fukui Y, Nagaoka K, Ono C, Matsuura Y, Niimi H, Yamamoto Y. Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population. J Infect Chemother 2022:S1341-321X(22)00158-1. [PMID: 35691864 DOI: 10.1016/j.jiac.2022.05.009] [Reference Citation Analysis]
50 Johnson MG, Puenpatom A, Moncada PA, Burgess L, Duke ER, Ohmagari N, Wolf T, Bassetti M, Bhagani S, Ghosn J, Zhang Y, Wan H, Williams-Diaz A, Brown ML, Paschke A, De Anda C. Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial. Ann Intern Med 2022. [PMID: 35667065 DOI: 10.7326/M22-0729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
51 Hager KJ, Pérez Marc G, Gobeil P, Diaz RS, Heizer G, Llapur C, Makarkov AI, Vasconcellos E, Pillet S, Riera F, Saxena P, Geller Wolff P, Bhutada K, Wallace G, Aazami H, Jones CE, Polack FP, Ferrara L, Atkins J, Boulay I, Dhaliwall J, Charland N, Couture MMJ, Jiang-Wright J, Landry N, Lapointe S, Lorin A, Mahmood A, Moulton LH, Pahmer E, Parent J, Séguin A, Tran L, Breuer T, Ceregido MA, Koutsoukos M, Roman F, Namba J, D'Aoust MA, Trepanier S, Kimura Y, Ward BJ; CoVLP Study Team. Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine. N Engl J Med 2022;386:2084-96. [PMID: 35507508 DOI: 10.1056/NEJMoa2201300] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
52 Bignon E, Marazzi M, Monari A. Hijacking of Cellular Functions by Severe Acute Respiratory Syndrome Coronavirus-2. Permeabilization and Polarization of the Host Lipid Membrane by Viroporins. J Phys Chem Lett 2022;13:4642-9. [PMID: 35593652 DOI: 10.1021/acs.jpclett.2c01102] [Reference Citation Analysis]
53 Jeewandara C, Aberathna IS, Pushpakumara PD, Kamaladasa A, Guruge D, Wijesinghe A, Gunasekera B, Ramu ST, Kuruppu H, Ranasinghe T, Dayarathna S, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Jayathilaka D, Dissanayake M, Jayadas TT, Mudunkotuwa A, Somathilake G, Harvie M, Nimasha T, Danasekara S, Wijayamuni R, Schimanski L, Rijal P, Tan TK, Dong T, Townsend A, Ogg GS, Malavige GN. Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine. Immun Inflamm Dis 2022;10:e621. [PMID: 35634958 DOI: 10.1002/iid3.621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Islam F, Dhawan M, Nafady MH, Emran TB, Mitra S, Choudhary OP, Akter A. Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions. Annals of Medicine and Surgery 2022;78:103737. [DOI: 10.1016/j.amsu.2022.103737] [Reference Citation Analysis]
55 Stosic M, Milic M, Markovic M, Kelic I, Bukumiric Z, Veljkovic M, Kisic Tepavcevic D, Saponjic V, Plavsa D, Jovanovic S, Jovanovic V. Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia. Vaccines (Basel) 2022;10:838. [PMID: 35746446 DOI: 10.3390/vaccines10060838] [Reference Citation Analysis]
56 Bignon E, Marazzi M, Grandemange S, Monari A. Autophagy and evasion of the immune system by SARS-CoV-2. Structural features of the non-structural protein 6 from wild type and Omicron viral strains interacting with a model lipid bilayer. Chem Sci 2022;13:6098-105. [PMID: 35685814 DOI: 10.1039/d2sc00108j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Lupașcu (Moisi) RE, Ilie MI, Velescu BȘ, Udeanu DI, Sultana C, Ruță S, Arsene AL. COVID-19-Current Therapeutical Approaches and Future Perspectives. Processes 2022;10:1053. [DOI: 10.3390/pr10061053] [Reference Citation Analysis]
58 Liwsrisakun C, Pata S, Laopajon W, Takheaw N, Chaiwong W, Inchai J, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Chuensirikulchai K, Kasinrerk W. Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine. Immun Ageing 2022;19:24. [PMID: 35610643 DOI: 10.1186/s12979-022-00279-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Brazete C, Pinto M, Sá L, Aguiar A, Alves F, Duarte R. Evaluation of the Real-World Effectiveness of Vaccines against COVID-19 at a Local Level: Protocol for a Test-Negative Case-Control Study. Vaccines (Basel) 2022;10:822. [PMID: 35632578 DOI: 10.3390/vaccines10050822] [Reference Citation Analysis]
60 Bachelet VC, Silva-Ayarza I, Lizana FJ, Gomolán P, Silva-Villalobos D, Navarrete MS. SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol. BMJ Open 2022;12:e061345. [PMID: 35589344 DOI: 10.1136/bmjopen-2022-061345] [Reference Citation Analysis]
61 Wang X, Rcheulishvili N, Cai J, Liu C, Xie F, Hu X, Yang N, Hou M, Papukashvili D, He Y, Wang PG. Development of DNA Vaccine Candidate against SARS-CoV-2. Viruses 2022;14:1049. [DOI: 10.3390/v14051049] [Reference Citation Analysis]
62 Li Y, Rao M, Xu G. New-Onset Acute Kidney Disease Post COVID-19 Vaccination. Vaccines 2022;10:742. [DOI: 10.3390/vaccines10050742] [Reference Citation Analysis]
63 Dhawan M, Sharma A, Priyanka, Thakur N, Rajkhowa TK, Choudhary OP. Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions. Hum Vaccin Immunother 2022;:2068883. [PMID: 35507895 DOI: 10.1080/21645515.2022.2068883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Zabalza A, Arrambide G, Otero-Romero S, Pappolla A, Tagliani P, López-Maza S, Cárdenas-Robledo S, Esperalba J, Fernández-Naval C, Martínez-Gallo M, Castillo M, Bonastre M, Resina-Salles M, Bertran J, Rodriguez-Barranco M, Carbonell-Mirabent P, Gonzalez M, Merchan M, Quiroga-Varela A, Miguela A, Gómez I, Álvarez G, Robles R, Perez Del Campo D, Queralt X, Soler MJ, Agraz I, Martinez-Valle F, Rodríguez-Acevedo B, Midaglia L, Vidal-Jordana Á, Cobo-Calvo Á, Tur C, Galan I, Castillo J, Río J, Espejo C, Comabella M, Nos C, Sastre-Garriga J, Ramió-Torrentà L, Tintoré M, Montalban X. Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases? Mult Scler 2022;:13524585221089540. [PMID: 35475363 DOI: 10.1177/13524585221089540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
65 Zhang M, Gong Y, Jiao S. Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent. Future Virology. [DOI: 10.2217/fvl-2021-0100] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Ballesteros-sanabria L, Pelaez-prestel HF, Ras-carmona A, Reche PA. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants. Biomedicines 2022;10:996. [DOI: 10.3390/biomedicines10050996] [Reference Citation Analysis]
67 Pavan M, Bassani D, Sturlese M, Moro S. Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? J Enzyme Inhib Med Chem 2022;37:1077-82. [PMID: 35418253 DOI: 10.1080/14756366.2022.2062336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Soraci L, Lattanzio F, Soraci G, Gambuzza ME, Pulvirenti C, Cozza A, Corsonello A, Luciani F, Rezza G. COVID-19 Vaccines: Current and Future Perspectives. Vaccines 2022;10:608. [DOI: 10.3390/vaccines10040608] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Premikha M, Chiew CJ, Wei WE, Leo YS, Ong B, Lye DC, Lee VJ, Tan KB. Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore. Clin Infect Dis 2022:ciac288. [PMID: 35412612 DOI: 10.1093/cid/ciac288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Li Q, Zhang M, Liang Z, Zhang L, Wu X, Yang C, An Y, Tong J, Liu S, Li T, Cui Q, Nie J, Wu J, Huang W, Wang Y. Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD. MedComm 2022;3. [DOI: 10.1002/mco2.130] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
71 Cavani M, Riofrío WA, Arciniega M. Molecular Dynamics and MM-PBSA Analysis of the SARS-CoV-2 Gamma Variant in Complex with the hACE-2 Receptor. Molecules 2022;27:2370. [PMID: 35408761 DOI: 10.3390/molecules27072370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Chavda VP, Bezbaruah R, Athalye M, Parikh PK, Chhipa AS, Patel S, Apostolopoulos V. Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena. Viruses 2022;14:759. [DOI: 10.3390/v14040759] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
73 Madewell ZJ, Yang Y, Longini IM Jr, Halloran ME, Dean NE. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis. JAMA Netw Open 2022;5:e229317. [PMID: 35482308 DOI: 10.1001/jamanetworkopen.2022.9317] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
74 Cazzato G, Romita P, Foti C, Lobreglio D, Trilli I, Colagrande A, Ingravallo G, Resta L. Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation? Vaccines 2022;10:532. [DOI: 10.3390/vaccines10040532] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Yang J, Liao Y, Hua Q, Lv H. A Survey of Awareness of COVID-19 Knowledge, Willingness and Influencing Factors of COVID-19 Vaccination. Vaccines 2022;10:524. [DOI: 10.3390/vaccines10040524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Belete TM. The Immune Response, Safety, and Efficacy of Emergency Use Authorization-Granted COVID-19 Vaccines: A Review. TOMICROJ 2022;16:e187428582201240. [DOI: 10.2174/18742858-v16-e2201240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Ullah M, Mubashir M, Atique H, Aslam F, Tahir M, Naqvi M. COVID-19 Infection in Vaccinated Healthcare Professionals. Cureus. [DOI: 10.7759/cureus.23386] [Reference Citation Analysis]
78 Cañas CA, Posso-osorio I, Bedoya-joaqui V, López HE, Tobón GJ. An idiotypic network dysregulation could be related to the pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT) following vaccination with vaccines expressing Spike protein of SARS CoV2. Intern Emerg Med. [DOI: 10.1007/s11739-022-02956-4] [Reference Citation Analysis]
79 Oroszi B, Juhász A, Nagy C, Horváth JK, Komlós KE, Túri G, Mckee M, Ádány R. Characteristics of the Third COVID-19 Pandemic Wave with Special Focus on Socioeconomic Inequalities in Morbidity, Mortality and the Uptake of COVID-19 Vaccination in Hungary. JPM 2022;12:388. [DOI: 10.3390/jpm12030388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
80 Xiong X, Wong CKH, Au ICH, Lai FTT, Li X, Wan EYF, Chui CSL, Chan EWY, Cheng FWT, Lau KTK, Lee CH, Woo YC, Lui DTW, Wong ICK. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study. Thyroid 2022;32:505-14. [PMID: 35216517 DOI: 10.1089/thy.2021.0684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
81 Ghazy RM, Ashmawy R, Hamdy NA, Elhadi YAM, Reyad OA, Elmalawany D, Almaghraby A, Shaaban R, Taha SHN. Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. Vaccines 2022;10:350. [DOI: 10.3390/vaccines10030350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
82 Jutel M, Torres MJ, Palomares O, Akdis CA, Eiwegger T, Untersmayr E, Barber D, Zemelka-Wiacek M, Kosowska A, Palmer E, Vieths S, Mahler V, Canonica WG, Nadeau K, Shamji MH, Agache I. COVID-19  vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations. Allergy 2022. [PMID: 35147230 DOI: 10.1111/all.15252] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Porru S, Spiteri G, Monaco MGL, Valotti A, Carta A, Lotti V, Diani E, Lippi G, Gibellini D, Verlato G. Post-Vaccination SARS-CoV-2 Infections among Health Workers at the University Hospital of Verona, Italy: A Retrospective Cohort Survey. Vaccines 2022;10:272. [DOI: 10.3390/vaccines10020272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
84 Zhao F, Ma Q, Yue Q, Chen H. SARS-CoV-2 Infection and Lung Regeneration. Clin Microbiol Rev 2022;:e0018821. [PMID: 35107300 DOI: 10.1128/cmr.00188-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Terpos E, Karalis V, Ntanasis-stathopoulos I, Evangelakou Z, Gavriatopoulou M, Manola MS, Malandrakis P, Gianniou DD, Kastritis E, Trougakos IP, Dimopoulos MA. Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222. Biomedicines 2022;10:338. [DOI: 10.3390/biomedicines10020338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
86 Giannini S, Giusti A, Minisola S, Napoli N, Passeri G, Rossini M, Sinigaglia L. The Immunologic Profile of Vitamin D and Its Role in Different Immune-Mediated Diseases: An Expert Opinion. Nutrients 2022;14:473. [PMID: 35276834 DOI: 10.3390/nu14030473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
87 Madewell ZJ, Yang Y, Longini IM Jr, Halloran ME, Dean NE. Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis. medRxiv 2022:2022. [PMID: 35043125 DOI: 10.1101/2022.01.09.22268984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
88 Bocchino M, Rea G, Buonocore A, Lieto R, Mazzocca A, Di Domenico A, Stanziola AA. Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination. Respiratory Medicine Case Reports 2022;38:101674. [DOI: 10.1016/j.rmcr.2022.101674] [Reference Citation Analysis]
89 Becskei A, Rahaman S. The life and death of RNA across temperatures. Computational and Structural Biotechnology Journal 2022;20:4325-36. [DOI: 10.1016/j.csbj.2022.08.008] [Reference Citation Analysis]
90 Dambadarjaa D, Altankhuyag GE, Chandaga U, Khuyag SO, Batkhorol B, Khaidav N, Dulamsuren O, Gombodorj N, Dorjsuren A, Singh P, Nyam G, Otganbayar D, Tserennadmid N. Factors Associated with COVID-19 Vaccine Hesitancy in Mongolia: A Web-Based Cross-Sectional Survey. Int J Environ Res Public Health 2021;18:12903. [PMID: 34948511 DOI: 10.3390/ijerph182412903] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
91 Weinberger B. Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population. Vaccines (Basel) 2021;9:1435. [PMID: 34960181 DOI: 10.3390/vaccines9121435] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
92 Sariol CA, Serrano-Collazo C, Ortiz EJ, Pantoja P, Cruz L, Arana T, Atehortua D, Pabon-Carrero C, Espino AM. Limited Impact of Delta Variant's Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population. Viruses 2021;13:2405. [PMID: 34960674 DOI: 10.3390/v13122405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]